These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32977814)

  • 1. Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Bonadia N; Bruno P; Angelini F; Di Stasi C; Contegiacomo A; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Sep; 19(1):147. PubMed ID: 32977814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Angelini F; Cina A; Iezzi R; Filipponi M; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Oct; 19(1):170. PubMed ID: 33028322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Cytokines Associated With Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes.
    Biscetti F; Ferraro PM; Hiatt WR; Angelini F; Nardella E; Cecchini AL; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Diabetes Care; 2019 Oct; 42(10):1939-1945. PubMed ID: 31371431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population.
    Rando MM; Biscetti F; Cecchini AL; Nardella E; Nicolazzi MA; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Gasbarrini A; Massetti M; Flex A
    Cardiovasc Diabetol; 2022 Oct; 21(1):214. PubMed ID: 36244983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study.
    Nardella E; Biscetti F; Rando MM; Cecchini AL; Nicolazzi MA; Rossini E; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Massetti M; Gasbarrini A; Flex A
    Cardiovasc Diabetol; 2023 Jun; 22(1):136. PubMed ID: 37308885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects.
    Biscetti F; Bonadia N; Santini F; Angelini F; Nardella E; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
    Cardiovasc Diabetol; 2019 Jan; 18(1):5. PubMed ID: 30634965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.
    Kaplovitch E; Eikelboom JW; Dyal L; Aboyans V; Abola MT; Verhamme P; Avezum A; Fox KAA; Berkowitz SD; Bangdiwala SI; Yusuf S; Anand SS
    JAMA Cardiol; 2021 Jan; 6(1):21-29. PubMed ID: 32997098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes.
    Schneider F; Saulnier PJ; Gand E; Desvergnes M; Lefort N; Thorin E; Thorin-Trescases N; Mohammedi K; Ragot S; Ricco JB; Hadjadj S
    Cardiovasc Diabetol; 2018 Jun; 17(1):81. PubMed ID: 29879997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
    Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
    J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease.
    Golledge J; Rowbotham S; Velu R; Quigley F; Jenkins J; Bourke M; Bourke B; Thanigaimani S; Chan DC; Watts GF
    J Am Heart Assoc; 2020 Mar; 9(6):e015355. PubMed ID: 32172653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study.
    Szczeklik W; Krzanowski M; Maga P; Partyka Ł; Kościelniak J; Kaczmarczyk P; Maga M; Pieczka P; Suska A; Wachsmann A; Górka J; Biccard B; Devereaux PJ
    Clin Res Cardiol; 2018 Apr; 107(4):319-328. PubMed ID: 29177795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sortilin/Omentin-1 ratio in peripheral artery disease: A cross-sectional study on 295 unselected elderly patients.
    Giovannini S; Biscetti F; Brau F; Biscotti L; Santoliquido A; Pitocco D; Bernabei R; Flex A
    Mech Ageing Dev; 2022 Jul; 205():111677. PubMed ID: 35500800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Klotho and FGF23 in cardiovascular outcomes of diabetic patients with chronic limb threatening ischemia: a prospective study.
    Biscetti F; Rando MM; Cecchini AL; Nicolazzi MA; Rossini E; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Gasbarrini A; Massetti M; Flex A
    Sci Rep; 2023 Apr; 13(1):6150. PubMed ID: 37061530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study.
    Malmstedt J; Kärvestedt L; Swedenborg J; Brismar K
    Cardiovasc Diabetol; 2015 Jul; 14():93. PubMed ID: 26216409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Is Associated with Improved Survival and Decreased Cardiac Events with No Impact on Patency and Limb Salvage after Revascularization for Peripheral Arterial Disease.
    Khan SZ; Rivero M; Nader ND; Cherr GS; Harris LM; Dryjski ML; Dosluoglu HH
    Ann Vasc Surg; 2019 Feb; 55():63-77. PubMed ID: 30081159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis.
    Bonaca MP; Bhatt DL; Simon T; Fox KM; Mehta S; Harrington RA; Leiter LA; Capell WH; Held C; Himmelmann A; Ridderstråle W; Chen J; Lee JJ; Song Y; Andersson M; Prats J; Kosiborod M; McGuire DK; Steg PG
    J Am Coll Cardiol; 2024 Apr; 83(17):1627-1636. PubMed ID: 38658101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes in diabetic patients with chronic limb-threatening ischemia.
    Liang P; Soden PA; Zettervall SL; Shean KE; Deery SE; Guzman RJ; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2018 Aug; 68(2):487-494. PubMed ID: 29576404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.